Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

Clinical trial condition

Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

Explore clinical trials studying Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma trial results

Active, Not Recruiting

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

NCT04697940

Conditions: Decitabine-primed Tandem CD19/CD20 CAR T Cells, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details